AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹154-162

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹438-460

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹63-65

ksquare

Open On08 Dec 2025

Close On10 Dec 2025

Price Range₹95 -₹100

ksquare

Open On08 Dec 2025

Close On10 Dec 2025

Price Range₹227-239

ksquare

Open On08 Dec 2025

Close On10 Dec 2025

Price Range₹131-138


Testimonial

Genuine Review Form Statisifed Customers

4.6 Out of 5 (58 Reviews)

KSquare’s SIP has brought structure to my investment plan. It's great for disciplined investing, and the automation ensures I never miss a payment. Very happy with the service so far!

Ankit Desai

Ankit Desai

Entrepreneur

I found KSquare’s NFO guides super user-friendly. They cover risks and benefits without overwhelming new investors. Highly recommended for anyone starting out.

Isha Kapoor

Isha Kapoor

Makeup Artist

The fund selection process at KSquare is simple yet thorough. Their insights helped me diversify properly and reduce risk effectively. Very pleased!

Abhinav Kohli

Abhinav Kohli

Petroleum Engineer

KSquare offered expert financial advice tailored to NRI needs. Their responsive team and secure platform earned my trust right away.

Rajat Verma

Rajat Verma

Software Architect

NPS through KSquare was a seamless experience. Their regular updates and advice on risk levels helped a lot.

Arvind Joshi

Arvind Joshi

Telecom Consultant

Very few services feel as reliable as KSquare’s NRI Corner. Their consistent communication and legal clarity made my decisions easier.

Dev Mehta

Dev Mehta

Aerospace Engineer

KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.

Harsh Vardhan

Harsh Vardhan

Energy Analyst

I never imagined saving for the future could be this easy. KSquare’s SIP service is transparent, reliable, and perfect for professionals like me looking to invest smartly.

Priya Mehta

Priya Mehta

Marketing Manager

KSquare’s loan facility saved me during a financial crunch. I didn’t need to touch my investments—very helpful!

Rajeev Kapoor

Rajeev Kapoor

Plant Manager

KSquare offered everything I needed to invest from the UK. Their NRI Corner is efficient, clear, and built with trust.

Rhea Menon

Rhea Menon

Fashion Designer

FAQ's

Frequenlty Asked Question

Can I invest in an NFO online with KSquare?

Yes, KSquare’s digital platform enables secure and quick online investments in NFOs with just a few clicks.

What are the benefits of investing in SIP through KSquare?

KSquare offers easy tracking, expert advice, and a simple setup to help you invest regularly and meet financial goals.

What if I need money before my SIP goal time?

Some SIP funds offer liquidity options, allowing partial withdrawals whenever required without disturbing the entire investment plan.

How much money do I need to start investing in mutual funds?

You can begin with as little as ₹500, making mutual funds accessible to new and seasoned investors alike.

How are NFO units allotted after subscription closes?

After the subscription period, units are allotted based on the face value and investment amount on the allotment date.

Is there a lock-in period for mutual fund investments?

Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.

Can I cancel or modify my NFO investment once submitted?

No, once submitted during the NFO period, investments cannot be modified or canceled. KSquare recommends careful planning.

How do I track my NPS account with KSquare?

You can log in to your KSquare dashboard to see real-time NAVs, contributions, and returns from your NPS account.

App Store